|Last Price||Today's Change||52-Week Range||Trading Volume|
|50.61||-0.62 (-1.22%)||31.85 - 53.68||3.5 million (Below Avg)|
Market data as of 2:11PM 12/11/13. Quotes are delayed by at least 15 min.
Bristol-Myers Squibb Names Thomas J. Lynch, Jr., M.D. to Board of Directors
12/10/2013 4:35 PM ET
Four-Year Data from Phase 3 DASISION Trial Comparing Sprycel® (dasatinib) to Imatinib in First-Line Treatment of Adults with Ph+ CP-CML Presented at Annual Meeting of the American Society of Hematology
12/09/2013 6:30 PM ET